CAI Accelerates Operational Readiness and Excellence across the Life Sciences and Mission-Critical Space for a Future of Precision, Innovation & Efficiency
Operational readiness and operational excellence are crucial to the life sciences and mission critical industries, as they are highly regulated and require stringent compliance standards....
Read More
Equipment Is Ready, But Are Your Operators? The Case for Prioritizing Training
In the pharmaceutical manufacturing world, regular collaboration between teams is critical for success; for example, project managers, department managers, quality assurance leads, engineers, and sterility...
Read More
The Future of AI-Driven Operational Readiness – An Outcome-Based Approach to Enhanced Process Validation and Asset Performance
As AI and related technologies continue to advance, the potential to reshape operational readiness grows exponentially. The future of AI for use in operational readiness...
Read More
The Near Future of AI in Operational Readiness – Automating Tedious Tasks to Augment Daily Execution
Through slow but sure incorporation, AI is now supporting operational readiness efforts by automating and augmenting the routine, repetitive tasks that often slow down daily...
Read More
CAI Unveils Bold New Brand Identity at ISPE Annual Meeting & Expo
Orlando, FL – [October 14, 2024] – CAI, a trailblazer in operational readiness and excellence, is thrilled to announce a comprehensive rebranding initiative, set to launch...
Read More
CAI Appoints Sheena Dempsey as Chief Executive Officer
Indianapolis (October 2, 2024)—CAI, a global professional services firm and trailblazer in operational readiness and excellence, today announced Sheena Dempsey as Chief Executive Officer (CEO)....
Read More
How Digital Twins are Optimizing Biotechnology Production and Changing the Workforce for the Future
The workforce is transforming rapidly, driven by technological advancements like Digital Twins. These virtual models replicate real-world systems in a digital space, and their integration...
Read More
The Handover Stage of Technology Transfer: Ensuring a Seamless Transition for Commercial Production
Transitioning from technology transfer (TT) to routine commercial production poses significant challenges for biopharmaceutical companies. Ensuring a seamless handover from the TT Team to the...
Read More
LESSONS LEARNED FROM IMPLEMENTING THE FDA’s CSA GUIDANCE: PART 3 –SUMMARIZING
This is the last installment of a three-article series that presents several lessons learned by our validation team while completing a pair of validation projects...
Read More
Planning for a Talented Workforce: Building a Staffing Plan for New or Expanding GMP Facilities
Let’s contrast two very real scenarios: You are responsible for bringing a new GMP facility or line to full-scale production. Your board or shareholders expect...
Read More